αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma
Abstract:BackgroundαB-crystallin is able to modulate vascular endothelial growth factor (VEGF) secretion. In many solid tumors VEGF is associated with angiogenesis, metastasis formation and poor prognosis. We set out to assess whether αB-crystallin expression is correlated with worse prognosis and whether this is related to VEGF secretion and cell motility in head and neck squamous cell carcinoma (HNSCC).MethodsαB-crystallin expression was determined immunohistochemically in tumor biopsies of 38 HNSCC patients. Locoreg… Show more
“…For example, Shi et al8 found that CRYAB promoted the invasion and metastasis of colorectal cancer cells via EMT. Consistently, Chantal et al suggested CRYAB as a useful biomarker to help fine‐tune treatment in head and neck squamous cell carcinoma, possibly by targeting CRYAB‐mediated cell motility 9. Obviously, these findings provide evidence delineating the pivotal role of CRYAB in cancer invasion and metastasis.…”
Section: Discussionmentioning
confidence: 76%
“…Interestingly, recent studies have revealed that CRYAB is aberrantly overexpressed in various types of cancer, and its expression could promote cell invasion and metastasis 8, 9, 10. For example, Shi et al8 found that CRYAB promoted the invasion and metastasis of colorectal cancer cells via EMT.…”
Alpha B‐crystallin (CRYAB) is overexpressed in a variety of cancers. However, little is known about its specific function and regulatory mechanism in gastric cancer. Here, we first explore the role of CRYAB in gastric cancer progression and metastasis. The expression of CRYAB was determined by western blot and immunohistochemistry in gastric cancer tissues. Besides, methods including stably transfected against CRYAB into gastric cancer cells, western blot, migration and invasion assays in vitro and metastasis assay in vivo were also conducted. The expression of CRYAB is up‐regulated in gastric cancer tissues compared with matched normal tissues. High expression level of CRYAB is closely correlated with cancer metastasis and shorter survival time in patients with gastric cancer. Additionally, CRYAB silencing significantly suppresses epithelial‐mesenchymal transition (EMT), migration and invasion of gastric cancer cells in vitro and in vivo, whereas CRYAB overexpression dramatically reverses these events. Mechanically, CRYAB facilitates gastric cancer cells invasion and metastasis via nuclear factor‐κ‐gene binding (NF‐κB)‐regulated EMT. These findings suggest that CRYAB expression predicts a poor prognosis in patients with gastric cancer. Besides, CRYAB contributes to gastric cancer cells migration and invasion via EMT, mediated by the NF‐κB signalling pathway, thus possibly providing a novel therapeutic target for gastric cancer.
“…For example, Shi et al8 found that CRYAB promoted the invasion and metastasis of colorectal cancer cells via EMT. Consistently, Chantal et al suggested CRYAB as a useful biomarker to help fine‐tune treatment in head and neck squamous cell carcinoma, possibly by targeting CRYAB‐mediated cell motility 9. Obviously, these findings provide evidence delineating the pivotal role of CRYAB in cancer invasion and metastasis.…”
Section: Discussionmentioning
confidence: 76%
“…Interestingly, recent studies have revealed that CRYAB is aberrantly overexpressed in various types of cancer, and its expression could promote cell invasion and metastasis 8, 9, 10. For example, Shi et al8 found that CRYAB promoted the invasion and metastasis of colorectal cancer cells via EMT.…”
Alpha B‐crystallin (CRYAB) is overexpressed in a variety of cancers. However, little is known about its specific function and regulatory mechanism in gastric cancer. Here, we first explore the role of CRYAB in gastric cancer progression and metastasis. The expression of CRYAB was determined by western blot and immunohistochemistry in gastric cancer tissues. Besides, methods including stably transfected against CRYAB into gastric cancer cells, western blot, migration and invasion assays in vitro and metastasis assay in vivo were also conducted. The expression of CRYAB is up‐regulated in gastric cancer tissues compared with matched normal tissues. High expression level of CRYAB is closely correlated with cancer metastasis and shorter survival time in patients with gastric cancer. Additionally, CRYAB silencing significantly suppresses epithelial‐mesenchymal transition (EMT), migration and invasion of gastric cancer cells in vitro and in vivo, whereas CRYAB overexpression dramatically reverses these events. Mechanically, CRYAB facilitates gastric cancer cells invasion and metastasis via nuclear factor‐κ‐gene binding (NF‐κB)‐regulated EMT. These findings suggest that CRYAB expression predicts a poor prognosis in patients with gastric cancer. Besides, CRYAB contributes to gastric cancer cells migration and invasion via EMT, mediated by the NF‐κB signalling pathway, thus possibly providing a novel therapeutic target for gastric cancer.
“…The role of the expression rates of integrin alpha-3 for locoregional and ITGB4 for haematogenous dissemination and, therefore, cancer cell motility and anchorage-independent survival, which are vital for OSCC recurrence and metastasis, has previously been shown. Furthermore, the importance of integrin beta1 in HNSCC and stimulated vascular endothelial growth factor secretion by alphaB-crystallin in HNSCC was specified [100,101] . In addition to these considerations, there might be a spread of tumour-derived molecules on a subcellular level, such as micro-RNAs.…”
Section: A Discussion Of the Results From Studies On Head And Neck Camentioning
Due to a lack of substantial improvement in the outcome of patients suffering from oral squamous cell carcinoma (OSCC) during the past decades, current staging methods need to be revised. This disease is associated with poor survival rates despite considerable advances in diagnosis and treatment. The early detection of metastases is an important indicator of survival, prognosis and relapse. Therefore, a better understanding of the mechanisms underlying metastasis is crucial. Exploring alternative measures apart from common procedures is needed to identify new prognostic markers. Similar to previous findings predominantly for other solid tumours, recently published studies demonstrate that circulating tumour cells (CTCs) and disseminated tumour cells (DTCs) might serve as prognostic markers and could supplement routine staging in OSCC. Thus, the detection of CTCs/DTCs is a promising tool to determine the individual need for therapeutic intervention. Encouraging results and new approaches point to the future use of targeted therapies for OSCC, an exceedingly heterogeneous subgroup of head and neck cancer. This review focuses on summarising technologies currently used to detect CTCs/DTCs. The translational relevance for OSCC is highlighted. The inherent challenges in detecting CTCs/DTCs will be emphasised. Core tip: Oral squamous cell carcinoma (OSCC), among head and neck cancer, is related to poor survival rates despite considerable advances in diagnosis and treatment. Therefore, detecting tumour cell dissemination early and understanding the underlying mechanisms are crucial for predicting prognosis, relapse and survival. According to previous findings, circulating tumour cells (CTCs) and disseminated tumour cells (DTCs) might serve as prognostic markers to supplement routine staging and support determining individual therapeutic interventions. This review focuses on summarising the current knowledge about the detection of CTCs/DTCs with special emphasis on patients suffering from OSCC. The translational relevance of CTCs/DTCs and challenges for clinical application are highlighted.Wikner J, Gröbe A, Pantel K, Riethdorf S. Squamous cell carcinoma of the oral cavity and circulating tumour cells.
“…Overexpression of HspB5 can transform immortalized human mammary epithelial cells that can develop invasive mammary carcinomas in nude mice with basal-like breast tumor features (Moyano et al 2006 ). Consequently HspB5 can be considered as a biomarker in the diagnosis of breast cancers, especially in those with advanced grade (Ivanov et al 2008 ;Sitterding et al 2008 ;Tsang et al 2012 ). Similarly, high levels of HspB5 are associated with low survival rate in hepatocellular carcinoma (Huang et al 2013 ;Tang et al 2009 ), ovarian carcinoma (Volkmann et al 2013 ), clear cell renal cell carcinoma (Ho et al 2013 ) and head and neck squamous cell carcinoma (van de Schootbrugge et al 2013 ).…”
HspB5, also called αB-crystallin, is a ubiquitous small heat shock protein (sHSP) that is strongly induced by a variety of stresses, but that also functions constitutively in multiple cell types. Extensive research has demonstrated that HspB5 acts as an ATP-independent molecular chaperone by binding unfolding proteins and protecting cells from damage due to irreversible protein aggregation. As a result of its importance in protein homeostasis HspB5 is of signifi cant interest to many areas of cell biology, including the development of cancer. However, the molecular understanding of HspB5's role in cancer is only beginning to emerge. In this chapter an overview is given of data that provide insight into the oncogenic role of HspB5 in human cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.